iodoHis(3)- neurokinin A (INKA)

Also Known As:

INKA; neurokinin A, iodoHis(3)-; 125I-iodohistidyl neurokinin A; 3-iodohistidyl neurokinin A; neurokinin A, iodohistidyl(3)-

Networked: 13 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Kinins: 2029
      - Tachykinins: 869
        Neurokinin A: 269
        iodoHis(3)- neurokinin A: 13
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Tachykinins: 869
        Neurokinin A: 269
        iodoHis(3)- neurokinin A: 13
- Peptides: 82426
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Kinins: 2029
    - Tachykinins: 869
      - Neurokinin A: 269
        iodoHis(3)- neurokinin A: 13
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Kinins: 2029
      - Tachykinins: 869
        Neurokinin A: 269
        iodoHis(3)- neurokinin A: 13

Experts

1.	Jimenez, Connie R: 2 articles (09/2020 - 12/2019)
2.	Piersma, Sander R: 2 articles (09/2020 - 12/2019)
3.	Barberena, Ramiro: 1 article (12/2020)
4.	Benítez, Anahí: 1 article (12/2020)
5.	Cardillo, Marcelo: 1 article (12/2020)
6.	Cornejo, Luis: 1 article (12/2020)
7.	Cortegoso, Valeria: 1 article (12/2020)
8.	Da Peña, Gabriela: 1 article (12/2020)
9.	Durán, Víctor A: 1 article (12/2020)
10.	Falabella, Fernanda: 1 article (12/2020)

Related Diseases

1.	Wounds and Injuries (Trauma) 05/01/2006 - "As the Late Intermediate waned and environmental conditions improved, trauma concomitantly decreased (7.0%), and remained low throughout the Inka occupation (AD 1400-1532). " 01/01/1964 - "[TREATMENT OF NEWBORN INFANTS WITH INTRACRANIAL TRAUMA IN MICROCLIMATE CONDITIONS (IN THE "INKA" INCUBATOR)]."
2.	Neoplasms (Cancer) 12/01/2019 - "To demonstrate utility, we analyzed (i) cancer cell lines with known oncogenes, (ii) cell lines in a differential setting (wild-type versus mutant, +/- drug), (iii) pre- and on-treatment tumor needle biopsies, (iv) cancer cell panel with available drug sensitivity data, and (v) patient-derived tumor xenografts with INKA-guided drug selection and testing. " 03/28/2015 - "Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial." 01/01/2007 - "Responding tumors showed restoration of Fhit, Wwox, p16(INKa), Rassf1a expression, low mitotic activity, high apoptotic fraction and activation of caspase 3. These preclinical studies show the therapeutic potential of restoration of tumor suppressor expression through epigenetic modulation and the promise of re-expressed tumor suppressors as markers and effectors of the responses." 08/01/2001 - "We investigated 67 meningothelial tumors (20 benign meningiomas, 34 atypical meningiomas, and 13 anaplastic meningiomas) for losses of genetic information from chromosome arms 1p and 9p, as well as for deletion, mutation, and expression of the tumor suppressor genes CDKN2A (p16(INKa)/MTS1), p14(ARF), CDKN2B (p15(INK4b)/MTS2) (all located at 9p21) and CDKN2C (1p32). "
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/15/2002 - "Deletion analysis of p16(INKa) and p15(INKb) in relapsed childhood acute lymphoblastic leukemia."
4.	Psychotic Disorders (Schizoaffective Disorder) 08/17/2022 - "We report a case of non-affective psychosis with a brief discussion of the phenomenology and its characterization and treatment by traditional Inka healers and eventually by Western-trained psychiatrists. "
5.	Meningioma (Meningiomas) 08/01/2001 - "We investigated 67 meningothelial tumors (20 benign meningiomas, 34 atypical meningiomas, and 13 anaplastic meningiomas) for losses of genetic information from chromosome arms 1p and 9p, as well as for deletion, mutation, and expression of the tumor suppressor genes CDKN2A (p16(INKa)/MTS1), p14(ARF), CDKN2B (p15(INK4b)/MTS2) (all located at 9p21) and CDKN2C (1p32). "

Related Drugs and Biologics

1.	Caspase 3 (Caspase-3)
2.	Tumor Suppressor Protein p14ARF (p14ARF)
3.	Phosphotransferases (Kinase)
4.	Enzymes
5.	DNA (Deoxyribonucleic Acid)

Related Therapies and Procedures

1.	Therapeutics